HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Julie M Janssen Selected Research

Julie M Janssen Research Topics

Disease

5Neoplasms (Cancer)
01/2021 - 11/2017
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 01/2021
2Prostatic Neoplasms (Prostate Cancer)
01/2021 - 10/2019
1Disease Progression
01/2022
1Infertility (Sterility)
01/2021
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2020
1Critical Illness (Critically Ill)
10/2017

Drug/Important Bio-Agent (IBA)

2Docetaxel (Taxotere)FDA Link
01/2021 - 01/2021
2Phosphotransferases (Kinase)IBA
01/2020 - 12/2018
1ErbB Receptors (EGF Receptor)IBA
01/2022
1Circulating Tumor DNAIBA
01/2022
1alectinibIBA
01/2021
1CrizotinibIBA
01/2021
1Anaplastic Lymphoma KinaseIBA
01/2021
1Doxorubicin (Adriamycin)FDA LinkGeneric
01/2021
1Epirubicin (Ellence)FDA LinkGeneric
01/2021
1Paclitaxel (Taxol)FDA LinkGeneric
01/2021
1Ritonavir (Norvir)FDA Link
01/2021
1Bortezomib (Velcade)FDA Link
01/2020
1abirateroneIBA
10/2019
1Gentamicins (Gentamicin)FDA LinkGeneric
10/2017

Therapy/Procedure

2Castration
01/2021 - 10/2019
1Investigational Therapies (Experimental Therapy)
11/2017